
TY  - JOUR
TI  - Surgical Research Society abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 67
IS  - 11
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.1800671119
DO  - doi:10.1002/bjs.1800671119
SP  - 815
EP  - 836
PY  - 1980
ER  - 

TY  - JOUR
AU  - Andrews, Matthew T.
TI  - Advances in molecular biology of hibernation in mammals
JO  - BioEssays
JA  - Bioessays
VL  - 29
IS  - 5
SN  - 0265-9247
UR  - https://doi.org/10.1002/bies.20560
DO  - doi:10.1002/bies.20560
SP  - 431
EP  - 440
PY  - 2007
AB  - Abstract Mammalian hibernation is characterized by profound reductions in metabolism, oxygen consumption and heart rate. As a result, the animal enters a state of suspended animation where core body temperatures can plummet as low as ?2.9°C. Not only can hibernating mammals survive these physiological extremes, but they also return to a normothermic state of activity without reperfusion injury or other ill effects. This review examines recent findings on the genes, proteins and small molecules that control the induction and maintenance of hibernation in mammals. The molecular events involved with remodeling metabolism, inducing hypothermia and maintaining organ function are discussed and considered with respect to analogous processes in non-hibernating mammals such as mice and humans. The advent of sequenced genomes from three distantly related hibernators, a bat, hedgehog and ground squirrel, provides additional opportunities for molecular biologists to explore the mechanistic aspects of this biological adaptation in greater detail. BioEssays 29:431?440, 2007. ? 2007 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - FREE ORALS: BILIARY
JO  - HPB
VL  - 14
IS  - s2
SN  - 1365-182X
UR  - https://doi.org/10.1111/j.1477-2574.2012.00511.x
DO  - doi:10.1111/j.1477-2574.2012.00511.x
SP  - 107
EP  - 287
PY  - 2012
ER  - 

TY  - JOUR
TI  - ACVIM Forum Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 21
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2007.tb03006.x
DO  - doi:10.1111/j.1939-1676.2007.tb03006.x
SP  - 559
EP  - 670
PY  - 2007
ER  - 

TY  - JOUR
AU  - Das, Somak
AU  - Swain, Sudeepta K
AU  - Ramamurthy, Anand
TI  - Hepatic infarction from portal vein thrombosis: A fatal consequence of acute pancreatitis
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 18
IS  - 7
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12474
DO  - doi:10.1111/1751-2980.12474
SP  - 425
EP  - 427
PY  - 2017
ER  - 

TY  - JOUR
AU  - Svechtarova, Mila I.
AU  - Buzzacchera, Irene
AU  - Toebes, B. Jelle
AU  - Lauko, Jan
AU  - Anton, Nicoleta
AU  - Wilson, Christopher J.
TI  - Sensor Devices Inspired by the Five Senses: A Review
JO  - Electroanalysis
JA  - Electroanalysis
VL  - 28
IS  - 6
SN  - 1040-0397
UR  - https://doi.org/10.1002/elan.201600047
DO  - doi:10.1002/elan.201600047
SP  - 1201
EP  - 1241
KW  - medical device
KW  - wearable
KW  - sensor
KW  - transduction
KW  - GPCR
PY  - 2016
AB  - Abstract Wearable devices (wearables) have recently gained significant traction and are predicted to dominate many areas of research over the next 5 years. Many wearables contain a host of sensors that feedback vital bodily parameters to a central system. Although many artificial sensors exist, the biggest challenge to medical wearables is to interface and harness the ?big data? set from the human bodies own complex sensor network to better allow early diagnosis and/or treatment and prevention of diseases that have a huge economic burden on society such as type II diabetes. Cybernetics and medicine are joining their forces to overcome the new challenges in developing smarter, more intuitive and smaller sensors that interface with the human sensory system. This review is focused on the interface of devices to ion-mediated transduction pathways both through G-Coupled Protein Receptors and direct or mechanically transduced ion pathways.
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 2009 ACVIM Forum & Canadian Veterinary Medical Association Convention
JO  - Journal of Veterinary Internal Medicine
VL  - 23
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2009.0316.x
DO  - doi:10.1111/j.1939-1676.2009.0316.x
SP  - 673
EP  - 786
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Abstracts – 16 September
JO  - Journal of Gastroenterology and Hepatology
VL  - 23
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2008.05627.x
DO  - doi:10.1111/j.1440-1746.2008.05627.x
SP  - A116
EP  - A163
PY  - 2008
ER  - 

TY  - JOUR
TI  - 2015 ACVIM Forum Research Abstract Program
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 29
IS  - 4
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12609
DO  - doi:10.1111/jvim.12609
SP  - 1122
EP  - 1256
PY  - 2015
ER  - 

TY  - JOUR
TI  - Paediatric Research Society of Australia Abstracts of Papers Presented at the 16th Annual Meeting, Surfers Paradise, 19th May, 1983
JO  - Journal of Paediatrics and Child Health
VL  - 19
IS  - 3
SN  - 1034-4810
UR  - https://doi.org/10.1111/j.1440-1754.1983.tb02093.x
DO  - doi:10.1111/j.1440-1754.1983.tb02093.x
SP  - 192
EP  - 199
PY  - 1983
ER  - 

TY  - JOUR
TI  - Abstracts—Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Re
VL  - 43
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.14059
DO  - doi:10.1111/acer.14059
SP  - 27A
EP  - 258A
PY  - 2019
ER  - 

TY  - JOUR
AU  - Berney, Thierry
AU  - Boffa, Catherine
AU  - Augustine, Titus
AU  - Badet, Lionel
AU  - de Koning, Eelco
AU  - Pratschke, Johann
AU  - Socci, Carlo
AU  - Friend, Peter
TI  - Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group
JO  - Transplant International
JA  - Transpl Int
VL  - 29
IS  - 7
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12681
DO  - doi:10.1111/tri.12681
SP  - 798
EP  - 806
KW  - donation after cardiac death
KW  - donation after circulatory death
KW  - guidelines
KW  - islet of Langerhans
KW  - non-heart beating donation
KW  - pancreas
KW  - review
PY  - 2016
AB  - Summary Donation after circulatory death (DCD) donors are increasingly being used as a source of pancreas allografts for vascularized organ and islet transplantation. We provide practice guidelines aiming to increase DCD pancreas utilization. We review risk assessment and donor selection criteria. We report suggested factors in donor and recipient clinical management and provide an overview of the activities and outcomes of vascularized pancreas and islet transplantation.
ER  - 

TY  - JOUR
TI  - E-Poster Exhibition | APDW 2019
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 34
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.14865
DO  - doi:10.1111/jgh.14865
SP  - 583
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
AU  - Munir, Fahad
AU  - Jamshed, Muhammad B.
AU  - Shahid, Numan
AU  - Muhammad, Syed A.
AU  - Ghanem, Noor B.
AU  - Qiyu, Zhang
C7  - e14170
TI  - Current status of diagnosis and Mesenchymal stem cells therapy for acute pancreatitis
JO  - Physiological Reports
JA  - Physiol Rep
VL  - 7
IS  - 21
SN  - 2051-817X
UR  - https://doi.org/10.14814/phy2.14170
DO  - doi:10.14814/phy2.14170
SP  - e14170
KW  - Acute pancreatitis
KW  - inflammation
KW  - mesenchymal stem cells
KW  - systemic inflammatory response syndrome
PY  - 2019
AB  - Abstract Acute pancreatitis (AP) is an acute gastrointestinal disorder that is the most common and requiring emergency hospitalization. Its incidence is increasing worldwide, thus increasing the burden of medical services. Approximately 20% of the patients develop moderate to severe necrotizing pancreatitis associated with pancreatic or peri-pancreatic tissue necrosis and multiple organ failure. There are many reports about the anti-inflammatory effect of mesenchymal stem cells (MSCs) on pancreatitis and the repair of tissue damage. MSCs cells come from a wide range of sources, autologous MSCs come from bone marrow and allogeneic MSCs such as umbilical cord blood MSCs, placenta-derived MSCs, etc. The wide source is not only an advantage of MSCs but also a disadvantage of MSCs. Because of different cell sources and different methods of collection and preparation, it is impossible to establish a unified standard method for evaluation of efficacy. The biggest advantage of iMSCs is that it can be prepared by a standardized process, and can be prepared on a large scale, which makes it easier to commercialize. This paper reviews the present status of diagnosis and progress of MSCs therapy for AP.
ER  - 

C7  - pp. 497-512
TI  - Index
SN  - 9783527316991
UR  - https://doi.org/10.1002/9783527622672.index
DO  - doi:10.1002/9783527622672.index
SP  - 497-512
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Neurochemistry
VL  - 109
IS  - s1
SN  - 9783527316991
UR  - https://doi.org/10.1111/j.1471-4159.2009.05927.x
DO  - doi:10.1111/j.1471-4159.2009.05927.x
SP  - 265
EP  - 313
PY  - 2009
ER  - 

TY  - JOUR
AU  - Flint, RS
AU  - Windsor, JA
TI  - The role of the intestine in the pathophysiology and management of severe acute pancreatitis
JO  - HPB
VL  - 5
IS  - 2
SN  - 9783527316991
UR  - https://doi.org/10.1080/13651820310001108
DO  - doi:10.1080/13651820310001108
SP  - 69
EP  - 85
KW  - Intestine
KW  - Ischaemia
KW  - Mods
KW  - Pancreatitis
KW  - Reperfusion
KW  - Sirs
PY  - 2003
AB  - Background The outcome of severe acute pancreatitis has scarcely improved in 10 years. Further impact will require new paradigms in pathophysiology and treatment. There is accumulating evidence to support the concept that the intestine has a key role in the pathophysiology of severe acute pancreatitis which goes beyond the notion of secondary pancreatic infection. Intestinal ischaemia and reperfusion and barrier failure are implicated in the development of multiple organ failure. Discussion Conventional management of severe acute pancreatitis has tended to ignore the intestine. More recent attempts to rectify this problem have included 1) resuscitation aimed at restoring intestinal blood flow through the use of appropriate fluids and splanchnic-sparing vasoconstrictors or inotropes; 2) enteral nutrition to help maintain the integrity of the intestinal barrier; 3) selective gut decontamination and prophylactic antibiotics to reduce bacterial translocation and secondary infection. Novel therapies are being developed to limit intestinal injury, and these include antioxidants and anti-cytokine agents. This paper focuses on the role of the intestine in the pathogenesis of severe acute pancreatitis and reviews the implications for management.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 9
IS  - S2
SN  - 9783527316991
UR  - https://doi.org/10.1080/13651820701427987
DO  - doi:10.1080/13651820701427987
SP  - 3
EP  - 76
PY  - 2007
ER  - 

C7  - pp. 129-174
TI  - Transporter Proteins
SN  - 9780470684443
UR  - https://doi.org/10.1002/9781118451908.ch5
DO  - doi:10.1002/9781118451908.ch5
SP  - 129-174
KW  - transporter proteins
KW  - classification
KW  - transporters
KW  - structural analysis
KW  - transporter families
KW  - pharmacological interest
KW  - cellular homeostasis
PY  - 2007
AB  - Summary This chapter contains sections titled: Introduction Classification Structural analysis of transporters Transporter families of pharmacological interest Transporters and cellular homeostasis Summary References
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 9780470684443
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 
